Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Marcucci

Showing results (411-420 of 476) with videos related to

Pageof 48
Sort By:
Blood|April 19, 2022
Disruption of dNTP homeostasis by ribonucleotide reductase hyperactivation overcomes AML differentiation blockadeHanying Wang, Xin He, Lei Zhang, et al.
Leukemia|April 17, 2020
Daratumumab induces mechanisms of immune activation through CD38+ NK cell targetingDomenico Viola, Ada Dona, Enrico Caserta, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 11, 2012
NCCN Clinical Practice Guidelines Acute myeloid leukemiaMargaret R O'Donnell, Camille N Abboud, Jessica Altman, et al.
Cancer Cell|November 17, 2012
Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylationAnjali Mishra, Shujun Liu, Gregory H Sams, et al.
Blood Advances|January 17, 2025
TP53 mutations are associated with CD19- relapse and inferior outcomes after blinatumomab in adults with ALLIbrahim Aldoss, Shanpeng Li, Jianying Zhang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 14, 2013
Acute myeloid leukemia, version 2.2013Margaret R O'Donnell, Martin S Tallman, Camille N Abboud, et al.
Haematologica|October 4, 2017
Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of <i>TP53</i> mutational statusIbrahim Aldoss, Anh Pham, Sierra Min Li, et al.
Blood Advances|July 11, 2022
Outcomes of allogeneic hematopoietic cell transplantation in adults with fusions associated with Ph-like ALLIbrahim Aldoss, Dongyun Yang, Vanina Tomasian, et al.
Blood|August 9, 2013
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignanciesJoshua J Oaks, Ramasamy Santhanam, Christopher J Walker, et al.
Blood|October 27, 2012
Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemiaChristopher J Hickey, Sebastian Schwind, Hanna S Radomska, et al.
Pageof 48

Showing results (411-420 of 476) with videos related to

Sort By:
Pageof 48
Blood|April 19, 2022
Disruption of dNTP homeostasis by ribonucleotide reductase hyperactivation overcomes AML differentiation blockadeHanying Wang, Xin He, Lei Zhang, et al.
Leukemia|April 17, 2020
Daratumumab induces mechanisms of immune activation through CD38+ NK cell targetingDomenico Viola, Ada Dona, Enrico Caserta, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 11, 2012
NCCN Clinical Practice Guidelines Acute myeloid leukemiaMargaret R O'Donnell, Camille N Abboud, Jessica Altman, et al.
Cancer Cell|November 17, 2012
Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylationAnjali Mishra, Shujun Liu, Gregory H Sams, et al.
Blood Advances|January 17, 2025
TP53 mutations are associated with CD19- relapse and inferior outcomes after blinatumomab in adults with ALLIbrahim Aldoss, Shanpeng Li, Jianying Zhang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 14, 2013
Acute myeloid leukemia, version 2.2013Margaret R O'Donnell, Martin S Tallman, Camille N Abboud, et al.
Haematologica|October 4, 2017
Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of <i>TP53</i> mutational statusIbrahim Aldoss, Anh Pham, Sierra Min Li, et al.
Blood Advances|July 11, 2022
Outcomes of allogeneic hematopoietic cell transplantation in adults with fusions associated with Ph-like ALLIbrahim Aldoss, Dongyun Yang, Vanina Tomasian, et al.
Blood|August 9, 2013
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignanciesJoshua J Oaks, Ramasamy Santhanam, Christopher J Walker, et al.
Blood|October 27, 2012
Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemiaChristopher J Hickey, Sebastian Schwind, Hanna S Radomska, et al.
Pageof 48